Spots Global Cancer Trial Database for Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung Cancer

Official Title: Study of Mutations of Epidermal Growth Factor Receptor in the Blood of Patients With Advanced Non Small Cell Lung Cancer

Study ID: NCT00899756

Conditions

Lung Cancer

Interventions

molecular diagnostic method

mutation analysis

Study Description

Brief Summary: RATIONALE: Collecting and storing samples of blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at epidermal growth factor receptor mutations in the blood of patients with advanced non-small cell lung cancer.

Detailed Description: OBJECTIVES: * Determine if epidermal growth factor receptor (EGFR) mutation exists in the peripheral blood of patients with advanced non-small cell lung cancer (NSCLC). * Estimate the frequency of EGFR mutation in these patients. * Correlate the presence of EGFR mutation in blood with EGFR mutation in primary or metastatic NSCLC tumor block. OUTLINE: Patients undergo blood collection for analysis of epidermal growth factor receptor mutation by DNA sequencing. PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.